Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
about
Role of bacteria in oncogenesisThe causal relation between human papillomavirus and cervical cancer.Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-AnalysisHost Organelle Hijackers: a similar modus operandi for Toxoplasma gondii and Chlamydia trachomatis: co-infection model as a tool to investigate pathogenesisAssociation of Genital Infections Other Than Human Papillomavirus with Pre-Invasive and Invasive Cervical NeoplasiaChlamydia infection depends on a functional MDM2-p53 axisProtection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.Multinucleation during C. trachomatis infections is caused by the contribution of two effector pathwaysEstrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule networkTransitional probability-based model for HPV clearance in HIV-1-positive adolescent females.Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohortChlamydia induces anchorage independence in 3T3 cells and detrimental cytological defects in an infection model.The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors.Infection and cervical neoplasia: facts and fiction.Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancerChlamydia trachomatis infection causes mitotic spindle pole defects independently from its effects on centrosome amplificationChlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors.Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposureNo association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia.Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia.Chlamydia trachomatis today: treatment, detection, immunogenetics and the need for a greater global understanding of chlamydial disease pathogenesisCentrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway.Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening.Detection of adeno-associated virus type 2 genome in cervical carcinoma.Are smoking and chlamydial infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies.A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland.Vaccines for Chlamydia infections of the female genital tract.Cytokinesis is blocked in mammalian cells transfected with Chlamydia trachomatis gene CT223.Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance.CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans.Listeria monocytogenes induces host DNA damage and delays the host cell cycle to promote infection.Chlamydia trachomatis infections of the female genital tract: state of the art.Prevalence and factors associated with Chlamydia trachomatis infection among women with HIV in São Paulo.Rectal chlamydia - should screening be recommended in women?Aerosolized Non-viral Nucleic Acid Delivery in the Vaginal Tract of Pigs.A Chlamydia effector recruits CEP170 to reprogram host microtubule organization.Chlamydia trachomatis infection: implications for HPV status and cervical cancer.
P2860
Q24633180-2D447565-5226-4AAD-B376-48D87ADBFA88Q24673148-96E087E5-6BF1-4883-B8F2-AF48E759B2B5Q26752543-0DDAC642-D18E-47A1-9597-452887E52101Q26825487-757E7785-CCED-4665-8830-CD99EBD45463Q28074146-25C17A25-3B5D-44B0-9634-0CC6BFC18E83Q30601745-984E35CB-47B5-4918-A7EB-1F91F49B1A34Q33588632-42991422-BF58-44A3-890F-B91BD2C70501Q33725156-B06FDF61-8172-42C5-9AE2-037DB5E16094Q33793765-FBA63AAA-E3D8-4417-BE0F-235863B0003EQ33850511-6FE210ED-3D7E-4739-8382-6A68DA3DD982Q34073220-4BEFAED2-A71D-43EF-A95A-6C9CB0C8D97FQ34146342-2CC07ABB-FC4C-4262-8B98-65C1DBA9DA6BQ34366883-04059BCF-2397-4EEF-8C7A-7D0664B22163Q34545451-16287095-DACE-4864-A270-40835B5FF451Q34635024-54284AB0-4291-481B-BE21-3E4167A495BEQ34843163-0CE6A85D-3631-4983-B174-A9A3E33E1E2EQ34854745-51A910B6-10D2-45AD-AD3E-76587A9A1689Q35049831-CC5061E0-992E-4349-9404-30732A405E7EQ35137772-29884005-543F-47F4-9B2E-D3345637DAE2Q35228757-B5BFA6BA-507E-43D5-915C-FDC94DBEAF2FQ35529240-86AA7EDF-E01B-447F-82A1-EA615E0C3880Q35531080-659E2D06-A617-4E13-B435-E3044F3A34C7Q35755413-F4389B10-AD5E-4531-B695-C78FF2156DFBQ35841813-C8278877-1E72-4B84-B87F-883FEABE7B14Q36201512-B2BB9B1D-3989-4BC6-AFE7-B3E4E81FB89BQ36494175-F780FF64-E5A4-43A4-A0A9-7450E937D9F8Q36614427-AD3C8CA8-0250-4F69-9AE5-523AC50C416FQ36671760-5732BE03-D972-4034-9A1D-5FAB788E9457Q36696933-04E860A0-405A-4C3E-AD7A-7F915CC2CD04Q37071155-491F4598-7D23-4DFF-9669-6A24A8CB0ED9Q37134011-CB2B687F-21AE-4BD1-8A17-FFEA8DF0A612Q37213033-45C87347-BAB9-427C-A31A-4DA5EBA41D1AQ37333434-67DC223C-6442-41BF-B304-9CA37397EE86Q37698900-08D2D7E6-F9A5-4BEA-B7F4-650CB8ADC4A0Q37834018-86939F53-A391-4F06-AC88-4B1F4FA96057Q37836025-115F0129-4AA6-479A-9F65-477E409CFDC9Q37836240-4003F1A3-0E22-4C83-9BFD-8FCFC96116F1Q37838639-7B971450-67DD-4D71-9528-E4A21DEFA689Q37839714-C592A16C-464A-4682-9BBC-50B3D8CAF5E5Q37845310-4CC229B8-4D2C-4BB0-BC5B-3F2834899E9D
P2860
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
@en
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
@nl
type
label
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
@en
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
@nl
prefLabel
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
@en
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
@nl
P2093
P1476
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
@en
P2093
A Brunsvig
J Paavonen
L Youngman
M Lehtinen
S Thoresen
P356
10.1002/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A
P577
2000-01-01T00:00:00Z